Autoimmunity in 2011. (Q38021696)

27 August 2017

title

Autoimmunity in 2011. (English)

1 reference

27 August 2017

1

Carlo Selmi

1 reference

27 August 2017

publication date

1 August 2012

1 reference

Clinical Reviews in Allergy & Immunology

27 August 2017

published in

1 reference

27 August 2017

volume

43

1 reference

27 August 2017

issue

1-2

1 reference

27 August 2017

page(s)

194-206

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

27 August 2017

1 reference

The importance of assessing medication exposure to the definition of refractory disease in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Fatigue in systemic lupus erythematosus: An association with reduced physical fitness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Refractory disease in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Follicular helper T cells in systemic lupus erythematosus: A potential therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Dietary factors regulate cytokines in murine models of systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

The dual nature of Ets-1: focus to the pathogenesis of systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Emerging biological drugs: A new therapeutic approach for Systemic Lupus Erythematosus. An update upon efficacy and adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Management of autoimmune neutropenia in Felty's syndrome and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Regulatory T cells in systemic lupus erythematosus (SLE); Role of peptide tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Systemic lupus erythematosus in Hispanics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Exon 6 variants carried on systemic lupus erythematosus (SLE) risk haplotypes modulate IRF5 function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Pathogenesis of systemic lupus erythematosus revisited 2011: end organ resistance to damage, autoantibody initiation and diversification, and HLA-DR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Microparticles as antigenic targets of antibodies to DNA and nucleosomes in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Inhibited expression of hematopoietic progenitor kinase 1 associated with loss of jumonji domain containing 3 promoter binding contributes to autoimmunity in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

A unique hybrid renal mononuclear phagocyte activation phenotype in murine systemic lupus erythematosus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

BAFF/APRIL inhibition decreases selection of naive but not antigen-induced autoreactive B cells in murine systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

IFN-α confers resistance of systemic lupus erythematosus nephritis to therapy in NZB/W F1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

MHC class I family proteins retard systemic lupus erythematosus autoimmunity and B cell lymphomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

New autoantigens in the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

β2-Glycoprotein-I based peptide regulate endothelial-cells tissue-factor expression via negative regulation of pGSK3β expression and reduces experimental-antiphospholipid-syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Thromboprophylaxis in carriers of antiphospholipid antibodies (APL) without previous thrombosis: "Pros" and "Cons".

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Does seronegative antiphospholipid syndrome really exist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Management of refractory cases of catastrophic antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Solid cancer, antiphospholipid antibodies, and venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Catastrophic antiphospholipid syndrome in a community-acquired methicillin-resistant Staphylococcus aureus infection: A review of pathogenesis with a case for molecular mimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Prevalence of metabolic syndrome in primary antiphospholipid syndrome patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

High intensity anticoagulation in the prevention of the recurrence of arterial thrombosis in antiphospholipid syndrome: 'PROS' and 'CONS'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Catastrophic antiphospholipid syndrome associated with methicillin-resistant Staphylococcus aureus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Systemic vascular diseases in the antiphospholipid syndrome. What is the best diagnostic choice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

The use of atomic force microscopy to study the pathologic effects of anti-annexin autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Systemic sclerosis refractory disease: from the skin to the heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: a retrospective cohort study and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

B cells in systemic sclerosis: a possible target for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Fibrosis and immune dysregulation in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Cellular players in angiogenesis during the course of systemic sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Immunogenetics of systemic sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Two faces of the same coin: Raynaud phenomenon and digital ulcers in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

The needs of patients with systemic sclerosis — What are the difficulties encountered?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Do infections facilitate the emergence of systemic sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Angiogenic cytokines and growth factors in systemic sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Atherosclerosis and macrovascular involvement in systemic sclerosis: Myth or reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Digestive tract involvement in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Fibrosis in systemic sclerosis: Emerging concepts and implications for targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Distinctive autoantibody profile in Mexican Mestizo systemic sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Activation of the activin A-ALK-Smad pathway in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Switching rheumatoid arthritis treatments: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Role of the complement system in rheumatoid arthritis and psoriatic arthritis: relationship with anti-TNF inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Anti-IL-17A therapy protects against bone erosion in experimental models of rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Anti-TNFα discontinuation in rheumatoid and psoriatic arthritis: is it possible after disease remission?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Immunosenescence and rheumatoid arthritis: does telomere shortening predict impending disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

The metabolic syndrome: The crossroads between rheumatoid arthritis and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Th17 cells can provide B cell help in autoantibody induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Angiogenesis in rheumatoid arthritis: a disease specific process or a common response to chronic inflammation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

B-cells and their targeting in rheumatoid arthritis--current concepts and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Inflammatory memories: is epigenetics the missing link to persistent stromal cell activation in rheumatoid arthritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

An overview on the genetic of rheumatoid arthritis: a never-ending story

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Rheumatoid arthritis: what is refractory disease and how to manage it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Extra-articular manifestations of rheumatoid arthritis: An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Novel autoantibody markers for early and seronegative rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Oral GABA treatment downregulates inflammatory responses in a mouse model of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

To B or not to B: role of B cells in pathogenesis of arthritis in HLA transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Nucleic acid-stimulated antigen-presenting cells trigger T cells to induce disease in a rat transfer model of inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Subcutaneous immunoglobulin in polymyositis and dermatomyositis: A novel application

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Hematological malignancy associated with polymyositis and dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Therapy of polymyositis and dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Primary biliary cirrhosis and Sjögren's syndrome: autoimmune epithelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

T cell clonal expansions detected in patients with primary biliary cirrhosis express CX3CR1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Electrophile-modified lipoic derivatives of PDC-E2 elicits anti-mitochondrial antibody reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

The meaning of anti-Ro and anti-La antibodies in primary Sjögren's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

An experimental protocol for the fractionation and 2DE separation of HeLa and A-253 cell lysates suitable for the identification of the individual antigenic proteome in Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Cellular microRNAs (miRNAs) and Sjögren’s syndrome: Candidate regulators of autoimmune response and autoantigen expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Multiple sclerosis in Caucasians and Latino Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Neuroantigen-specific CD8 regulatory T-cell function is deficient during acute exacerbation of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Presumed guilty: natural killer T cell defects and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

High levels of 15-oxygenated steroids in circulation of patients with multiple sclerosis: fact or fiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Immune-mediated adverse effects of biologicals used in the treatment of rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

The dangerous liaison between iNKT cells and dendritic cells: does it prevent or promote autoimmune diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

γδ T cells and multiple sclerosis: Friends, foes, or both?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Autoimmune disease: A role for new anti-viral therapies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

B cells undergo unique compartmentalized redistribution in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

PI3Kδ drives the pathogenesis of experimental autoimmune encephalomyelitis by inhibiting effector T cell apoptosis and promoting Th17 differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Chondroitin sulphate proteoglycans: Extracellular matrix proteins that regulate immunity of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Unexpected Role for Granzyme K in CD56bright NK Cell-Mediated Immunoregulation of Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Estrogen receptor α signaling in T lymphocytes is required for estradiol-mediated inhibition of Th1 and Th17 cell differentiation and protection against experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Role of HLA class II genes in susceptibility and resistance to multiple sclerosis: Studies using HLA transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Estriol Generates Tolerogenic Dendritic Cells In Vivo That Protect against Autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Virus expanded regulatory T cells control disease severity in the Theiler’s virus mouse model of MS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Heterologous immunity: immunopathology, autoimmunity and protection during viral infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

The increasing incidence and prevalence of female multiple sclerosis—A critical analysis of potential environmental factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Autoantibodies with enzymatic properties in human autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Limited sufficiency of antigen presentation by dendritic cells in models of central nervous system autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Autoreactive Tbet-positive CD4 T cells develop independent of classic Th1 cytokine signaling during experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Relationship between HLA-DRB1 polymorphism and susceptibility or resistance to multiple sclerosis in Caucasians: a meta-analysis of non-family-based studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Antigen-specific prevention of type 1 diabetes in NOD mice is ameliorated by OX40 agonist treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

IL-7 uniquely maintains FoxP3 adaptive Treg cells that reverse diabetes in NOD mice via integrin-β7-dependent localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

The recent rise in the frequency of type 1 diabetes: Who pulled the trigger?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Specific maternal microchimeric T cells targeting fetal antigens in β cells predispose to auto-immune diabetes in the child

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Accelerated progression from islet autoimmunity to diabetes is causing the escalating incidence of type 1 diabetes in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Critical co-stimulatory pathways in the stability of Foxp3 Treg cell homeostasis in Type I Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Prevention, but not cure, of autoimmune diabetes in a NOD.scid transfer model by FTY720 despite effective modulation of blood T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Leptin treatment confers clinical benefit at multiple stages of virally induced type 1 diabetes in BB rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Type 2 diabetes as an inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Inhibition of Autoimmune Diabetes by TLR2 Tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Cutting edge: accelerated autoimmune diabetes in the absence of LAG-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Development of autoimmune diabetes in the absence of detectable IL-17A in a CD8-driven virally induced model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Increased T cell proliferative responses to islet antigens identify clinical responders to anti-CD20 monoclonal antibody (rituximab) therapy in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Evidence that Cd101 is an autoimmune diabetes gene in nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Human Type 1 Diabetes Is Associated with T Cell Autoimmunity to Zinc Transporter 8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Exposure to IL-15 and IL-21 Enables Autoreactive CD8 T Cells To Respond to Weak Antigens and Cause Disease in a Mouse Model of Autoimmune Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Testing the role of P2X7 receptors in the development of type 1 diabetes in nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

TCR bias of in vivo expanded T cells in pancreatic islets and spleen at the onset in human type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Inducible Adeno-Associated Virus-Mediated IL-2 Gene Therapy Prevents Autoimmune Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Inhibition of type 1 diabetes correlated to a Lactobacillus johnsonii N6.2-mediated Th17 bias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Comment on “Therapeutic Targeting of Syk in Autoimmune Diabetes”

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Visualizing the role of Cbl-b in control of islet-reactive CD4 T cells and susceptibility to type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Discovery of low-affinity preproinsulin epitopes and detection of autoreactive CD8 T-cells using combinatorial MHC multimers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Differences in self-peptide binding between T1D-related susceptible and protective DR4 subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

The susceptibility of Aire(-/-) mice to experimental myasthenia gravis involves alterations in regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Blocking of IL-6 suppresses experimental autoimmune myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Complement and cytokine based therapeutic strategies in myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Lysine methylation of the NF-κB subunit RelA by SETD6 couples activity of the histone methyltransferase GLP at chromatin to tonic repression of NF-κB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Epigenetic repression of the Igk locus by STAT5-mediated recruitment of the histone methyltransferase Ezh2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Phosphoproteomic analysis reveals an intrinsic pathway for the regulation of histone deacetylase 7 that controls the function of cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Ribose 2'-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Human cytomegalovirus microRNA miR-US4-1 inhibits CD8( ) T cell responses by targeting the aminopeptidase ERAP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4 T cells by the microRNA miR-125b.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Autoantibodies to intracellular antigens: generation and pathogenetic role.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Autoimmune bullous diseases the spectrum of infectious agent antibodies and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

From vaccine practice to vaccine science: the contribution of human immunology to the prevention of infectious disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

HLA-DR3 restricted T cell epitope mimicry in induction of autoimmune response to lupus-associated antigen SmD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Epitope spreading of the anti-CYP2D6 antibody response in patients with autoimmune hepatitis and in the CYP2D6 mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Enforced expression of the apoptosis inhibitor Bcl-2 ablates tolerance induction in DNA-reactive B cells through a novel mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Conformational Melding Permits a Conserved Binding Geometry in TCR Recognition of Foreign and Self Molecular Mimics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Recognition of β-linked self glycolipids mediated by natural killer T cell antigen receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Autoimmune or auto-inflammatory syndrome induced by adjuvants (ASIA): Old truths and a new syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

'ASIA' - autoimmune/inflammatory syndrome induced by adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Systemic lupus erythematosus one disease or many?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Cardiovascular safety of anti-TNF-alpha therapies: facts and unsettled issues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Anti-CD 20 monoclonal antibody (rituximab) treatment for inflammatory ocular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Epidemiology and management of refractory lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Anti-TNF therapy: safety aspects of taking the risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Chikungunya virus envelope-specific human monoclonal antibodies with broad neutralization potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Italian multicentre study for application of a diagnostic algorithm in autoantibody testing for autoimmune rheumatic disease: Conclusive results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Dysregulated neutrophil–endothelial interaction in antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitides: Implications for pathogenesis and disease intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Autoantibody heritability in thyroiditis: IgG subclass contributions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

A New Zealand Black-derived locus suppresses chronic graft-versus-host disease and autoantibody production through nonlymphoid bone marrow-derived cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

MCAM-expressing CD4 T cells in peripheral blood secrete IL-17A and are significantly elevated in inflammatory autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Peroxisome Proliferator-Activated Receptor γ Is Required for CD4 T Cell-Mediated Lymphopenia-Associated Autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Coronin 1A is an essential regulator of the TGFβ receptor/SMAD3 signaling pathway in Th17 CD4( ) T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Human CD19( )CD25(high) B regulatory cells suppress proliferation of CD4( ) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

The SLAM family member CD48 (Slamf2) protects lupus-prone mice from autoimmune nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Transcriptional Control of Rapid Recall by Memory CD4 T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Caspase-1-processed cytokines IL-1beta and IL-18 promote IL-17 production by gammadelta and CD4 T cells that mediate autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

CD4 FOXP3 T regulatory cells in human autoimmunity: more than a numbers game

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

The transcription factor E4BP4 regulates the production of IL-10 and IL-13 in CD4 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Autoreactive Memory CD4 T Lymphocytes That Mediate Chronic Uveitis Reside in the Bone Marrow through STAT3-Dependent Mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Origins of CD4( ) effector and central memory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Development of memory-like autoregulatory CD8 T cells is CD4 T cell dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

CD4 T cell help and innate-derived IL-27 induce Blimp-1-dependent IL-10 production by antiviral CTLs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

CD4 CD25 Foxp3 Regulatory T Cells Are Dispensable for Controlling CD8 T Cell-Mediated Lung Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Decreased frequencies of CD4 CD25 Foxp3 cells and the potent CD103 subset in peripheral lymph nodes correlate with autoimmune disease predisposition in some strains of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Therapeutic potential of TGF-β-induced CD4( ) Foxp3( ) regulatory T cells in autoimmune diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Targeting pre-ligand assembly domain of TNFR1 ameliorates autoimmune diseases - an unrevealed role in downregulation of Th17 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Differential Requirements for Th1 and Th17 Responses to a Systemic Self-Antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

TLR9 in peritoneal B-1b cells is essential for production of protective self-reactive IgM to control Th17 cells and severe autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

CD8( ) T regulatory/suppressor cells and their relationships with autoreactivity and autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Increased T regulatory cells lead to development of Th2 immune response in male SJL mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Immune Regulation through Mitochondrion-Dependent Dendritic Cell Death Induced by T Regulatory Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Human NKT cells direct the differentiation of myeloid APCs that regulate T cell responses via expression of programmed cell death ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Regulatory T-Cell (Treg) hybridoma as a novel tool to study Foxp3 regulation and Treg fate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Epistatic suppression of fatal autoimmunity in New Zealand black bicongenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Human Dendritic Cell Subsets from Spleen and Blood Are Similar in Phenotype and Function but Modified by Donor Health Status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

IL-2: a two-faced master regulator of autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Nasal cardiac myosin peptide treatment and OX40 blockade protect mice from acute and chronic virally-induced myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Detecting oxysterols in the human circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Development of autoimmune nephritis in genetically asplenic and splenectomized BAFF transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Relationship between ZnT8Ab, theSLC30A8gene and disease progression in children with newly diagnosed type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

An altered peptide ligand corresponding to a novel epitope from heat-shock protein 60 induces regulatory T cells and suppresses pathogenic response in an animal model of adjuvant-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Correlations between islet autoantibody specificity and theSLC30A8genotype withHLA-DQB1and metabolic control in new onset type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

NKT Cells Are Required for Complete Freund's Adjuvant-Mediated Protection from Autoimmune Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Comparison of different IVIg preparations on IL-17 production by human Th17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-012-8330-2

Generation and expansion of regulatory human CD4( ) T-cell clones specific for pancreatic islet autoantigens

21 January 2018

1 reference

12 December 2020

High-titer GAD65 autoantibodies detected in adult diabetes patients using a high efficiency expression vector and cold GAD65 displacement

1 reference

12 December 2020

Elevated serum level of circulating syndecan-1 (CD138) in active systemic lupus erythematosus

1 reference

12 December 2020

The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ

1 reference

12 December 2020

Post-translational oxidative modification of β2-glycoprotein I and its role in the pathophysiology of the antiphospholipid syndrome

1 reference

12 December 2020

The three ZNT8 autoantibody variants together improve the diagnostic sensitivity of childhood and adolescent type 1 diabetes

1 reference

12 December 2020

Turning transcription on or off with STAT5: when more is less

1 reference

12 December 2020

Comment on "Type 1 diabetes in BioBreeding rats is critically linked to an imbalance between Th17 and regulatory T cells and an altered TCR repertoire"

1 reference

12 December 2020

Study of polymorphisms in 4q27, 10p15, and 22q13 regions in autoantibodies stratified type 1 diabetes patients

1 reference

12 December 2020

Distinct pathological patterns in relapsing–remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate

1 reference

12 December 2020

Antibody-mediated coengagement of FcγRIIb and B cell receptor complex suppresses humoral immunity in systemic lupus erythematosus

1 reference

12 December 2020

Invariant NKT Cell Reconstitution in Pediatric Leukemia Patients Given HLA-Haploidentical Stem Cell Transplantation Defines Distinct CD4 and CD4 − Subset Dynamics and Correlates with Remission State

1 reference

12 December 2020

The antigen specificity of the rheumatoid arthritis-associated ACPA directed to citrullinated fibrin is very closely restricted

1 reference

12 December 2020

1 reference

12 December 2020

Genes, epigenetic regulation and environmental factors: which is the most relevant in developing autoimmune diseases?

1 reference

12 December 2020

Transfer of cell membrane components via trogocytosis occurs in CD4 Foxp3 CD25 regulatory T-cell contact-dependent suppression

1 reference

12 December 2020

Th17 cells, not IL-17 γδ T cells, drive arthritic bone destruction in mice and humans

1 reference

12 December 2020

Serum CXCL10 levels and neuromuscular manifestations in patients with autoimmune thyroid diseases

1 reference

12 December 2020

A mimic of viral double-stranded RNA triggers fulminant type 1 diabetes-like syndrome in regulatory T cell-deficient autoimmune diabetic mouse

1 reference

12 December 2020

Therapeutic dosing of an orally active, selective cathepsin S inhibitor suppresses disease in models of autoimmunity

1 reference

12 December 2020

Killer Treg restore immune homeostasis and suppress autoimmune diabetes in prediabetic NOD mice

1 reference

12 December 2020

High Levels of Adenosine Deaminase on Dendritic Cells Promote Autoreactive T Cell Activation and Diabetes in Nonobese Diabetic Mice

1 reference

12 December 2020

Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases

1 reference

12 December 2020

TLR-dependent T cell activation in autoimmunity.

1 reference

12 December 2020

Peripheral blood lymphocytes analysis detects CD100/SEMA4D alteration in systemic sclerosis patients

1 reference

12 December 2020

Classification criteria for Sjogren's syndrome: a critical review

1 reference

12 December 2020

Interstitial lung disease in systemic sclerosis

1 reference

12 December 2020

The matricellular protein SPARC supports follicular dendritic cell networking toward Th17 responses

1 reference

12 December 2020

Effects of adalimumab therapy on disease activity and interferon-γ-mediated biochemical pathways in patients with rheumatoid arthritis

1 reference

12 December 2020

10.1007/S12016-012-8330-2

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1044436736

0 references

1 reference